Status:
TERMINATED
Proton Pump Inhibitor Therapy and Bone Density in Premature Infants
Lead Sponsor:
University of Utah
Conditions:
Osteopenia
Prematurity
Eligibility:
All Genders
Brief Summary
Previous research studies have shown that there may be a connection between proton pump inhibitor therapies and hip fracture in adults(1). Proton pump inhibitor(PPI) reflux medications raise the pH of...
Detailed Description
After a patient is screened and consent is obtained, participants will all be initially placed into group one. Patients will be later moved to group two if their treatment includes proton pump inhibit...
Eligibility Criteria
Inclusion
- Infants born between 24 and 34 weeks gestation and 600g to 2000g birth weight Parental consent has been obtained
Exclusion
- Infants with bone disorders, liver or kidney problems, infants of diabetics, growth retarded infants, or infants taking diuretics or chronic steroids will be excluded.
Key Trial Info
Start Date :
April 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2013
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT00888017
Start Date
April 1 2009
End Date
January 1 2013
Last Update
January 23 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Utah Health Sciences Center
Salt Lake City, Utah, United States, 84132